ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2123

Analysis of Lupus Synovitis Gene Expression Reveals Dysregulation of Pathogenic Pathways Activated within Infiltrating Immune Cells

Erika Hubbard, Michelle Catalina, Sarah Heuer, Prathyusha Bachali, Nick Geraci, Isabella Blanco, Robert Robl, Peter Lipsky and Amrie Grammer, AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, Bioinformatics, pathogenesis and synovium, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Arthritis is a common manifestation of SLE but the inflammatory and immune cells that infiltrate synovium and the signaling pathways activated are not well understood. Previous work delineated an IFN signature in lupus arthritis but not rheumatoid arthritis (RA) or osteoarthritis (OA)1. A multi-pronged bioinformatic approach was utilized to analyze gene expression from RA, OA and lupus arthritis (LA) samples to gain insight into the precise pathogenic mechanisms involved. 

Methods: Initial analyses examined genes that were similar and different between non-inflammatory OA, LA and RA synovial biopsy samples following LIMMA differential expression (DE) analysis or Weighted Gene Co-expression Network Analysis (WGCNA) followed by interrogation with cell type specific gene signatures using I-ScopeTM and validated by Gene Set Variation Analysis (GSVA). Genes were functionally characterized using BIG-CTM and pathways elucidated using the upstream regulator (UPR) and canonical pathway functions of IPAÒ.

Results: From BIG-CTM and I-ScopeTM analysis, lupus synovitis has a clear gene signature of activated antigen presenting cells including dendritic cells, inflammatory myeloid cells, activated CD4+ and CD8+ T cells, activated B cells as well as pre- and post- switch plasma cells/plasmablasts as indicated by IgM, IgD and IgG1 heavy chain genes. The presence of both Igk and Igl as well as numerous VL genes indicates the polyclonal nature of the infiltrate. Analysis of gene expression indicated no inflammatory infiltrate in OA and that RA is dominated by activated T and B cell signatures. IPA analysis tools examining canonical pathways and UPRs revealed the role of Sphingosine-1 phosphate receptor and numerous chemokine pathways that may mediate lymphocyte organization and/or recruitment into lupus synovium. In addition, IPA elucidated ongoing signaling induced by inflammatory cytokines. Moreover, signaling pathways including NF-kB, NF-AT and mTOR were evident as well as proliferation and proteasome activity. Important differences were observed in gene expression from lupus compared to RA synovitis, including tendencies of less enrichment of Th17 and Tcyotoxic, less frequent enrichment of TFH and increased enrichment of myeloid populations. In addition, IPA UPR analysis indicated ongoing signaling by TNF, IFNg, IFNa, CD40L, IL6, IL1b, IL15, IL21 and IL27 in lupus synovitis. 

Conclusion: Bioinformatic analysis of gene expression patterns in lupus synovitis indicate trafficking and potential in situ activation and differentiation of immune cells during pathogenesis of LA. Interestingly, a more prominent myeloid signature is present in LA compared with RA, that might provide a unique target of therapeutic intervention.

1Nzeusseu-Toukap, A., et al. (2007). Arthritis & Rheumatism, 56(5), 1579–1588.


Disclosure: E. Hubbard, None; M. Catalina, None; S. Heuer, None; P. Bachali, None; N. Geraci, None; I. Blanco, None; R. Robl, None; P. Lipsky, Janssen Research & Development, LLC, 2; A. Grammer, None.

To cite this abstract in AMA style:

Hubbard E, Catalina M, Heuer S, Bachali P, Geraci N, Blanco I, Robl R, Lipsky P, Grammer A. Analysis of Lupus Synovitis Gene Expression Reveals Dysregulation of Pathogenic Pathways Activated within Infiltrating Immune Cells [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/analysis-of-lupus-synovitis-gene-expression-reveals-dysregulation-of-pathogenic-pathways-activated-within-infiltrating-immune-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-lupus-synovitis-gene-expression-reveals-dysregulation-of-pathogenic-pathways-activated-within-infiltrating-immune-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology